Related Experiment Videos
The therapeutic potential of targeting adhesion molecules in rheumatoid arthritis
1Department of Medicine (Rheumatology Unit), Royal Postgraduate Medical School, Hammersmith Hospital, London.
Cell Adhesion and Communication
|July 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The exaggerated inflammatory response in Behçet's syndrome: identification of dysfunctional post-transcriptional regulation of the IFN-γ/CXCL10 IP-10 pathway.
Clinical and experimental immunology·2015
Methotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammation.
Annals of the rheumatic diseases·2015
Wireless capsule endoscopy in the investigation of intestinal Behçet's syndrome.
Rheumatology (Oxford, England)·2008
Modulation of heart fibroblast migration and collagen gel contraction by IGF-I.
Cell adhesion and communication·2000
Quantitative determination of gap junction intercellular communication using flow cytometric measurement of fluorescent dye transfer.
Cell adhesion and communication·2000
Sialidase treatment exposes the beta1-integrin active ligand binding site on HL60 cells and increases binding to fibronectin.
Cell adhesion and communication·2000
Localization of urokinase type plasminogen activator to focal adhesions requires ligation of vitronectin integrin receptors.
Cell adhesion and communication·2000
Co-localization of Rac1 and E-cadherin in human epidermal keratinocytes.
Cell adhesion and communication·2000
Soluble and cell-associated forms of the adhesion molecule LFA-3 (CD58) are differentially regulated by inflammatory cytokines.
Cell adhesion and communication·2000
Immune-Cell Profiling Identifies a Defective Macrophage-Maresin 1 Resolution Axis as a Pathogenic Driver and Therapeutic Target in Vitiligo and Canities.
Journal of cutaneous medicine and surgery·2026
SAVI: molecular mechanisms, clinical spectrum and precision medicine approaches beyond type-I IFN.
Frontiers in immunology·2026